EC Number   |
Disease |
PubMed ID |
Title of Publication  |
Category |
Confidence Level |
|---|
    1.13.11.11 | Neoplasms |
27469130 |
1,2,3-Triazoles as inhibitors of indoleamine 2,3-dioxygenase 2 (IDO2). |
causal interaction
therapeutic application
unassigned |
3
4
0 |
| 1.13.11.11 | Colorectal Neoplasms |
29607498 |
1-L-MT, an IDO inhibitor, prevented colitis-associated cancer by inducing CDC20 inhibition-mediated mitotic death of colon cancer cells. |
causal interaction
diagnostic usage
unassigned |
3
2
0 |
| 1.13.11.11 | Neoplasms |
31804586 |
4,5-Disubstituted 1,2,3-triazoles: Effective Inhibition of Indoleamine 2,3-Dioxygenase 1 Enzyme Regulates T cell Activity and Mitigates Tumor Growth. |
causal interaction
unassigned |
1
0 |
| 1.13.11.11 | Neoplasms |
30773421 |
4,6-Substituted-1H-Indazoles as potent IDO1/TDO dual inhibitors. |
causal interaction
ongoing research
therapeutic application
unassigned |
1
2
1
0 |
| 1.13.11.11 | Neoplasms |
29932010 |
A highly potent and selective inhibitor Roxyl-WL targeting IDO1 promotes immune response against melanoma. |
causal interaction
unassigned |
2
0 |
| 1.13.11.11 | Liver Diseases |
33569476 |
A narrative review of the roles of indoleamine 2,3-dioxygenase and tryptophan-2,3-dioxygenase in liver diseases. |
unassigned |
0 |
| 1.13.11.11 | Neoplasms |
28768924 |
A Novel High Throughput Virtual Screening Protocol to Discover New Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors. |
therapeutic application
unassigned |
4
0 |
| 1.13.11.11 | Leukemia, Myeloid, Acute |
29038460 |
A novel immunohistochemical score to predict early mortality in acute myeloid leukemia patients based on indoleamine 2,3 dioxygenase expression. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
3
3
1
1 |
| 1.13.11.11 | Neoplasms |
29473428 |
A patent review of IDO1 inhibitors for cancer. |
ongoing research
unassigned |
3
0 |
| 1.13.11.11 | Glioma |
32436060 |
A phase 1 study of PF-06840003, an oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor in patients with recurrent malignant glioma. |
ongoing research
therapeutic application
unassigned |
2
4
0 |
